Literature DB >> 6531666

The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population.

S Eriksson, S Lindgren.   

Abstract

We studied 33 patients with primary biliary cirrhosis representative of a well-defined population (240,000) during the decade 1973-82. Mean annual incidence was 13.7 per 10(6) and point prevalence, 92 per 10(6) inhabitants in 1982. An accumulation of asymptomatic cases, constituting 45% of all patients, with a normal life expectancy accounted for this high prevalence. During the study period no disease progress was seen in asymptomatic patients, in contrast to a 50% mortality in the symptomatic group. Disease progress in the latter group was reflected by deterioration of N-demethylating capacity and increasing bilirubin levels. Although our data confirm an increasing prevalence of primary biliary cirrhosis, the mortality rate during the study period was almost identical to that in an earlier period, 1951-60.

Entities:  

Mesh:

Year:  1984        PMID: 6531666

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

Review 1.  Primary biliary cirrhosis: new perspectives in diagnosis and treatment.

Authors:  M I Prince; D E Jones
Journal:  Postgrad Med J       Date:  2000-04       Impact factor: 2.401

2.  Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort.

Authors:  M I Prince; A Chetwynd; W L Craig; J V Metcalf; O F W James
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

Review 3.  Predicting the prognosis of primary biliary cirrhosis.

Authors:  J M Neuberger
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

Review 4.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

5.  Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data.

Authors:  H T Sorensen; A M Thulstrup; P Blomqvist; B Nørgaard; K Fonager; A Ekbom
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

6.  Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group.

Authors:  R G Watson; P W Angus; M Dewar; B Goss; R B Sewell; R A Smallwood
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

Review 7.  Recent advances in the development of farnesoid X receptor agonists.

Authors:  Ahmad H Ali; Elizabeth J Carey; Keith D Lindor
Journal:  Ann Transl Med       Date:  2015-01

Review 8.  Clinical features and management of primary biliary cirrhosis.

Authors:  Andrea Crosignani; Pier-Maria Battezzati; Pietro Invernizzi; Carlo Selmi; Elena Prina; Mauro Podda
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

9.  National incidence of autoimmune liver diseases and its relationship with the human development index.

Authors:  Hong-Ying Pan; Yi-Ning Dai; Ji-Na Zheng; Ke-Qing Shi; Sven Van Poucke; Hai Zou; Ming-Hua Zheng
Journal:  Oncotarget       Date:  2016-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.